Primary tabs

License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

Drugs to be Discontinued

Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable. These drugs include those that are life-supporting, life-sustaining or for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery). The discontinuations provided below reflect information received from manufacturers, and are for informational purposes only.

Source: OpenFDATest
FieldValue
Publisher
Modified
2013-09-26
Release Date
2013-09-26
Homepage URL
Identifier
6e72c239-0510-49f4-8404-d3d7d50351ec
License
License Not Specified
Contact Name
openFDA
Contact Email
Public Access Level
Public
Harvested from OpenFDATest
Harvest Source TitleOpenFDATest
Harvest Source URIhttps://open.fda.gov/data.json
Last Harvest PerformedThu, 01/10/2019 - 00:04